272 related articles for article (PubMed ID: 23755889)
1. Larynx preservation: what is the best non-surgical strategy?
Lagha A; Chraiet N; Labidi S; Rifi H; Ayadi M; Krimi S; Allani B; Raies H; Touati S; Boussen H; Kochbati L; Mezlini A
Crit Rev Oncol Hematol; 2013 Nov; 88(2):447-58. PubMed ID: 23755889
[TBL] [Abstract][Full Text] [Related]
2. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
Lefebvre JL; Ang KK;
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
[TBL] [Abstract][Full Text] [Related]
3. [Organ preservation in laryngeal and hypopharyngeal cancer].
Quer M; León X
Acta Otorrinolaringol Esp; 2007 Dec; 58(10):476-82. PubMed ID: 18082078
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B
Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of current and emerging approaches in the field of larynx preservation.
Denaro N; Russi EG; Lefebvre JL; Merlano MC
Radiother Oncol; 2014 Jan; 110(1):16-24. PubMed ID: 24139733
[TBL] [Abstract][Full Text] [Related]
6. Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.
Lefebvre JL; Ang KK;
Head Neck; 2009 Apr; 31(4):429-41. PubMed ID: 19283793
[TBL] [Abstract][Full Text] [Related]
7. [Squamous cell carcinoma of the hypopharynx and larynx: evidence-based care].
Fayette J; Pointreau Y; Bourhis J; Lefebvre JL
Bull Cancer; 2014 May; 101(5):438-44. PubMed ID: 24886894
[TBL] [Abstract][Full Text] [Related]
8. Larynx preservation.
Lefebvre JL
Curr Opin Oncol; 2012 May; 24(3):218-22. PubMed ID: 22450148
[TBL] [Abstract][Full Text] [Related]
9. Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease.
Suzuki G; Yamazaki H; Ogo E; Abe T; Eto H; Muraki K; Hattori C; Umeno H; Tanaka N; Tanaka T; Nakamura S; Yoshida K
Anticancer Res; 2014 Sep; 34(9):5205-10. PubMed ID: 25202116
[TBL] [Abstract][Full Text] [Related]
10. Organ preservation ... where do we stand?
Lefebvre JL
Acta Otorhinolaryngol Belg; 1999; 53(3):223-5. PubMed ID: 10635397
[TBL] [Abstract][Full Text] [Related]
11. [Proposal for the management of epithelial carcinoma of the larynx and hypopharynx].
Orv Hetil; 1989 Apr; 130(18):949-50. PubMed ID: 2726245
[No Abstract] [Full Text] [Related]
12. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
Li ZD; Lu T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
[No Abstract] [Full Text] [Related]
13. Combined modality treatment of laryngeal squamous cell carcinoma.
Devlin JG; Langer CJ
Expert Rev Anticancer Ther; 2007 Mar; 7(3):331-50. PubMed ID: 17338653
[TBL] [Abstract][Full Text] [Related]
14. Approaches to preserve larynx function in locally advanced laryngeal and hypopharyngeal cancer.
Rudat V; Pfreundner L; Hoppe F; Dietz A
Onkologie; 2004 Aug; 27(4):368-75. PubMed ID: 15347892
[TBL] [Abstract][Full Text] [Related]
15. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
Pfister DG; Strong E; Harrison L; Haines IE; Pfister DA; Sessions R; Spiro R; Shah J; Gerold F; McLure T
J Clin Oncol; 1991 May; 9(5):850-9. PubMed ID: 2016629
[TBL] [Abstract][Full Text] [Related]
16. Searching for less toxic larynx preservation: a need for common definitions and metrics.
Forastiere AA; Trotti AM
J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
[No Abstract] [Full Text] [Related]
17. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
[TBL] [Abstract][Full Text] [Related]
18. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Yamashita Y; Shiono O; Hirama M; Sakuma Y; Ishitoya J; Hata M; Ogino I; Oridate N
Cancer Chemother Pharmacol; 2013 Oct; 72(4):837-43. PubMed ID: 23959463
[TBL] [Abstract][Full Text] [Related]
19. [Pathomorphological aspects of transoral resection of hypopharyngeal carcinoma with preservation of the larynx. Patient selection, treatment results].
Glanz H
Laryngorhinootologie; 1999 Dec; 78(12):654-62. PubMed ID: 10666691
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma.
Prades JM; Lallemant B; Garrel R; Reyt E; Righini C; Schmitt T; Remini N; Saban-Roche L; Timoshenko AP; Trombert B; Guerrier B
Acta Otolaryngol; 2010; 130(1):150-5. PubMed ID: 19449227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
